Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: A case series

Paediatric Anaesthesia

Volumn 17, Issue 8, 2007, Pages 738-748

  Wang, Luke Y J ^a   Ross, Allison K ^a   Li, Jennifer S ^a   Dearmey, Stephanie M ^a   Mackey, Joanne F ^a   Worden, Maryalice ^b   Corzo, Deyanira ^b   Morgan, Claire ^b   Kishnani, Priya S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

Anesthesia; Arrhythmia; Cardiomyopathy; GSD II; Pompe disease; rhGAA enzyme replacement therapy

Indexed keywords

ADRENALIN; ALIMEMAZINE TARTRATE; AMBROXOL; AMIODARONE; ANTIANEMIC AGENT; ATROPINE; BICARBONATE; CALCIUM; DOPAMINE; ETOMIDATE; FENTANYL; FEREDETATE SODIUM; GLUCAN 1,4 ALPHA GLUCOSIDASE; KETAMINE; LIDOCAINE; MAGNESIUM; MESNA; MIDAZOLAM; MORPHINE SULFATE; PHENYLEPHRINE; PROPOFOL; RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE; ROCURONIUM; SEVOFLURANE; SUXAMETHONIUM; THIOPENTAL; TRICLOFOS; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASODILATOR AGENT; VASOPRESSIN; VECURONIUM; VERAPAMIL;

ANESTHESIA; ARTICLE; BRADYCARDIA; CLINICAL ARTICLE; CONTINUOUS INFUSION; CORONARY ARTERY BLOOD FLOW; DIASTOLIC BLOOD PRESSURE; DRUG DOSE INCREASE; ENZYME REPLACEMENT; FEMALE; GENERAL ANESTHESIA; GLYCOGEN STORAGE DISEASE TYPE 2; HEART ARREST; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOCALCEMIA; INFANT; IRON DEFICIENCY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; SURVIVAL; TORSADE DES POINTES;

ALPHA-GLUCOSIDASES; ANESTHESIA, GENERAL; ANESTHETICS, INTRAVENOUS; ARRHYTHMIA; CLINICAL TRIALS; FATAL OUTCOME; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HEART ARREST; HUMANS; INFANT; INFANT, NEWBORN; MALE; METHYL ETHERS; PROPOFOL; RETROSPECTIVE STUDIES;

EID: 34347209936     PISSN: 11555645     EISSN: 14609592     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2007.02215.x     Document Type: Article

References (32)

1. Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr 2004 144 : S35 S43.
2. Hirschhorn R, Reuser AJ. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In : Scriver CR, Beaudet AL, Sly WS et al., eds. The Metabolic and Molecular Bases of Inherited Disease. 8th edn. New York : McGraw-Hill, 2001 : 3389 3420.
3. van den Hout HM, Hop W, van Diggelen OP et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003 112 : 332 340.
4. Kishnani P, Hwu W-L, Mandel H et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 2006 148 : 671 676.
5. Ausems MG, Verbiest J, Hermans MP et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 1999 7 : 713 716.
6. Martiniuk F, Chen A, Mack A et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet 1998 79 : 69 72.
7. Ausems MG, ten Berg K, Kroos MA et al. Glycogen storage disease type II: birth prevalence agrees with predicted genotype frequency. Community Genet 1999 2 : 91 96.
8. Poorthuis BJ, Wevers RA, Kleijer WJ et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999 105 : 151 156.
9. Lin CY, Hwang B, Hsiao KJ, Jin YR. Pompe's disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity. J Inherit Metab Dis 1987 10 : 11 17.
10. Amalfitano A, Bengur AR, Morse RP et al. Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I/II clinical trial. Genet Med 2001 3 : 132 138.
11. Kishnani PS, Nicolino M, Voit T et al. Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr 2006 149 : 89 97.
12. Klinge L, Straub V, Neudorf U et al. Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial. Neuromuscul Disord 2005 15 : 24 31.
13. van den Hout H, Reuser AJ, Vulto AG et al. Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 2000 356 : 397 398.
14. van den Hout JM, Kamphoven JH, Winkel LP et al. Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 2004 113 : e448 e457.
15. van den Hout JM, Reuser AJ, de Klerk JB et al. Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk. J Inherit Metab Dis 2001 24 : 266 274.
16. Winkel LP, Kamphoven JH, van den Hout HJ et al. Morphological changes in muscle tissue of patients with infantile Pompe's disease receiving enzyme replacement therapy. Muscle Nerve 2003 27 : 743 751.
17. Ing RJ, Cook DR, Bengur RA et al. Anaesthetic management of infants with glycogen storage disease type II: a physiological approach. Pediatr Anesth 2004 14 : 514 519.
18. Bharati S, Serratto M, DuBrow I et al. The conduction system in Pompe's disease. Pediatr Cardiol 1982 2 : 25 32.
19. Cook AL, Kishnani PS, Carboni MP et al. Ambulatory electrocardiogram analysis in infants treated with recombinant human acid alpha glucosidase enzyme replacement therapy for Pompe disease. Genet Med 2006 8 : 313 317.
20. Ansong AK, Li JS, Nozik-Grayck E et al. Electrocardiographic response to enzyme replacement therapy for Pompe disease. Genet Med 2006 8 : 297 301.
21. Lebovic S, Reich DL, Steinberg LG et al. Comparison of propofol vs ketamine for anesthesia in pediatric patients undergoing cardiac catheterization. Anesth Analg 1992 74 : 490 494.
22. Oklu E, Bulutcu FS, Yalcin Y et al. Which anesthetic agent alters the hemodynamic status during pediatric catheterization? Comparison of propofol vs ketamine. J Cardiothorac Vasc Anesth 2003 17 : 686 690.
23. McFarlane HJ, Soni N. Pompe's disease and anaesthesia. Anaesthesia 1986 41 : 1219 1224.
24. Zhang H, Kallwass H, Young SP et al. A comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease. Genet Med 2006 8 : 302 306.
25. Chamoles NA, Niizawa G, Blanco M et al. Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper. Clin Chim Acta 2004 347 : 97 102.
26. Li Y, Scott CR, Chamoles NA et al. Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem 2004 50 : 1785 1796.
27. Umapathysivam K, Hopwood JJ, Meikle PJ. Determination of acid alpha-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clin Chem 2001 47 : 1378 1383.
28. Shin YS, Endres W, Unterreithmeier J et al. Diagnosis of Pompe's disease using leukocyte preparations. Kinetic and immunological studies of 1,4-alpha-glucosidase in human fetal and adult tissues and cultured cells. Clin Chim Acta 1985 148 : 9 19.
29. Dreyfus JC, Poenaru L. Alpha glucosidases in white blood cells, with reference to the detection of acid alpha 1-4 glucosidase deficiency. Biochem Biophys Res Commun 1978 85 : 615 622.
30. Jack RM, Gordon C, Scott CR et al. The use of acarbose inhibition in the measurement of acid alpha-glucosidase activity in blood lymphocytes for the diagnosis of Pompe disease. Genet Med 2006 8 : 307 312.
31. Rosen KR, Broadman LM. Anaesthesia for diagnostic muscle biopsy in an infant with Pompe's disease. Can Anaesth Soc J 1986 33 : 790 794.
32. Kishnani PS, Steiner RD, Bali D et al. Pompe disease diagnosis and management guidelines. Genet Med 2006 8 : 267 288.